​Frontage has developed a next-generation sequencing (NGS)-based method to rapidly determine the genotype of 300+ genes involved in ADME, called the Frontage PGx NGS Test.

Frontage Genomics successfully completed the Sponsor's request to transfer a method developed on MiSeq to MiniSeq.